Katarína Štingl

4.9k total citations · 1 hit paper
146 papers, 2.8k citations indexed

About

Katarína Štingl is a scholar working on Molecular Biology, Ophthalmology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Katarína Štingl has authored 146 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Molecular Biology, 49 papers in Ophthalmology and 45 papers in Cellular and Molecular Neuroscience. Recurrent topics in Katarína Štingl's work include Retinal Development and Disorders (77 papers), Retinal Diseases and Treatments (39 papers) and Neuroscience and Neural Engineering (33 papers). Katarína Štingl is often cited by papers focused on Retinal Development and Disorders (77 papers), Retinal Diseases and Treatments (39 papers) and Neuroscience and Neural Engineering (33 papers). Katarína Štingl collaborates with scholars based in Germany, Croatia and United States. Katarína Štingl's co-authors include Eberhart Zrenner, Florian Gekeler, Karl Ulrich Bartz‐Schmidt, Helmut Sachs, Udo Greppmaier, Barbara Wilhelm, Tobias Peters, Ákos Kusnyerik, Dorothea Besch and Anna Bruckmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Katarína Štingl

136 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Subretinal electronic chips allow blind patients to read letters and combine them to words

2010 626 citations Eberhart Zrenner, Karl Ulrich Bartz‐Schmidt et al. profile →

Peers

Countries citing papers authored by Katarína Štingl

Since Specialization

Citations

This map shows the geographic impact of Katarína Štingl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarína Štingl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarína Štingl more than expected).

Fields of papers citing papers by Katarína Štingl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarína Štingl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarína Štingl. The network helps show where Katarína Štingl may publish in the future.

Co-authorship network of co-authors of Katarína Štingl

This figure shows the co-authorship network connecting the top 25 collaborators of Katarína Štingl. A scholar is included among the top collaborators of Katarína Štingl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarína Štingl. Katarína Štingl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Single-guide RNA Cas9 and enhanced-deletion Cas9 rescue a recurrent USH2A-related splicing defect 2025 ·Molecular Therapy — Nucleic Acids ·Pietro De Angeli, (unknown), (unknown), (unknown), (unknown), (unknown), Katarína Štingl, Laura Kühlewein, Bernd Wissinger, Susanne Kohl	0
2	Simulating vision impairment in virtual reality: a comparison of visual task performance with real and simulated tunnel vision 2024 ·Virtual Reality ·Alexander Neugebauer, Nora Castner, (unknown), Katarína Štingl, Iliya V. Ivanov, Siegfried Wahl	5
3	Age-dependencies of the electroretinogram in healthy subjects 2024 ·Documenta Ophthalmologica ·(unknown), Melanie Kempf, (unknown), Fadi Nasser, Laura Kühlewein, Katarína Štingl, Krunoslav Stingl	4
4	Clinical and Genetic Findings in a Cohort of Patients with PRPF31-Associated Retinal Dystrophy 2024 ·American Journal of Ophthalmology ·(unknown), (unknown), Katarína Štingl, (unknown), Tobias B. Haack, Saskia Biskup, Bernd Wissinger, Nicole Weisschuh, Susanne Kohl, Laura Kühlewein	3
5	Visual Acuity, Full-field Stimulus Thresholds, and Electroretinography for 4 Years in The Rate of Progression of USH2A-related Retinal Degeneration (RUSH2A) Study 2024 ·SHILAP Revista de lepidopterología ·David G. Birch, Peiyao Cheng, Maureen G. Maguire, Jacque L. Duncan, Allison R. Ayala, Janet K. Cheetham, (unknown), Todd A. Durham, Abigail T. Fahim, Frederick L. Ferris, Rachel M. Huckfeldt, Michele Melia, Michel Michaelides, Mark E. Pennesi, (unknown), Katarína Štingl, Ajoy Vincent, Christina Y. Weng	0
6	RPE65-Associated Retinal Dystrophies: Phenotypes and Treatment Effects with Voretigene Neparvovec 2024 ·Klinische Monatsblätter für Augenheilkunde ·Katarína Štingl, Claudia Priglinger, Philipp Herrmann	1
7	Photoreceptor-Specific Temporal Contrast Sensitivities in RP1L1-Associated Occult Macular Dystrophy 2023 ·Investigative Ophthalmology & Visual Science ·Cord Huchzermeyer, (unknown), Jan Kremers, Laura Kühlewein, Melanie Kempf, (unknown), Krunoslav Stingl, Katarína Štingl	3
8	Biallelic Variants in TULP1 Are Associated with Heterogeneous Phenotypes of Retinal Dystrophy 2023 ·International Journal of Molecular Sciences ·(unknown), Valerio Marino, (unknown), Katarína Štingl, Tobias B. Haack, Saskia Biskup, Susanne Kohl, Laura Kühlewein, Daniele Dell’Orco, Nicole Weisschuh	5
9	Splicing defects and CRISPR-Cas9 correction in isogenic homozygous photoreceptor precursors harboring clustered deep-intronic ABCA4 variants 2023 ·Molecular Therapy — Nucleic Acids ·Pietro De Angeli, (unknown), Katarína Štingl, Laura Kühlewein, (unknown), Bernd Wissinger, Susanne Kohl	2
10	Full-field Scotopic Threshold Improvement after Voretigene Neparvovec-rzyl Treatment Correlates with Chorioretinal Atrophy 2023 ·Ophthalmology ·Katarína Štingl, Krunoslav Stingl, (unknown), Mark W. Reid, Melanie Kempf, Spyridon Dimopoulos, (unknown), Mark Borchert, Thomas C. M. Lee, Aaron Nagiel	29
11	Current Management of Inherited Retinal Degeneration Patients in Europe: Results of a 2-Year Follow-Up Multinational Survey by the European Vision Institute Clinical Research Network – EVICR.net 2023 ·Ophthalmic Research ·Birgit Lorenz, (unknown), L. Ingeborgh van den Born, João Pedro Marques, Elisabetta Pilotto, Katarína Štingl, Peter Charbel Issa, Dorothée Leroux, Hélène Dollfus, Hendrik P. N. Scholl, (unknown), (unknown)	4
12	Molecular Properties of Human Guanylate Cyclase-Activating Protein 3 (GCAP3) and Its Possible Association with Retinitis Pigmentosa 2022 ·International Journal of Molecular Sciences ·(unknown), (unknown), Nicole Weisschuh, Valerio Marino, (unknown), Katarína Štingl, Tobias B. Haack, Karl‐Wilhelm Koch, Daniele Dell’Orco	5
13	Development of retinal atrophy after subretinal gene therapy with voretigene neparvovec 2022 ·British Journal of Ophthalmology ·Felix F. Reichel, Immanuel P. Seitz, (unknown), Spyridon Dimopoulos, (unknown), Melanie Kempf, Susanne Kohl, (unknown), (unknown), (unknown), Krunoslav Stingl, Karl Ulrich Bartz‐Schmidt, Katarína Štingl, M. Dominik Fischer	50
14	Effective splicing restoration of a deep-intronic ABCA4 variant in cone photoreceptor precursor cells by CRISPR/SpCas9 approaches 2022 ·Molecular Therapy — Nucleic Acids ·Pietro De Angeli, (unknown), Stefan Hauser, Lüdger Schöls, Katarína Štingl, Bernd Wissinger, Susanne Kohl	11
15	A Novel, Apparently Silent Variant in MFSD8 Causes Neuronal Ceroid Lipofuscinosis with Marked Intrafamilial Variability 2022 ·International Journal of Molecular Sciences ·(unknown), Lena Zeltner, Karin Schäferhoff, (unknown), Theresia Zuleger, Tobias B. Haack, Antje Bornemann, Michael Alber, Susanne Ruf, Ludger Schoels, Katarína Štingl, Nicole Weisschuh	7
16	The STArgardt Remofuscin Treatment Trial (STARTT): design and baseline characteristics of enrolled Stargardt patients 2021 ·Open Research Europe ·(unknown), Philipp T. Möller, Camiel J.F. Boon, Andrew Lotery, Philipp Herrmann, Maurízio Battaglia Parodi, (unknown), Mario G. Fsadni, Thomas H. Wheeler‐Schilling, (unknown), H. Konrad Muller, Frank G. Holz, Steffen Schmitz-Valckenberg, Tobias Peters, Katarína Štingl, Carel B. Hoyng	7
17	Influence of Systematic Gaze Patterns in Navigation and Search Tasks with Simulated Retinitis Pigmentosa 2021 ·Brain Sciences ·Alexander Neugebauer, Katarína Štingl, Iliya V. Ivanov, Siegfried Wahl	5
18	Clinical Characteristics of POC1B-Associated Retinopathy and Assignment of Pathogenicity to Novel Deep Intronic and Non-Canonical Splice Site Variants 2021 ·International Journal of Molecular Sciences ·Nicole Weisschuh, (unknown), Miriam Bertrand, Tobias B. Haack, Bernd Wissinger, Susanne Kohl, Katarína Štingl	13
19	Clinical Phenotype of PDE6B-Associated Retinitis Pigmentosa 2021 ·International Journal of Molecular Sciences ·Laura Kuehlewein, Ditta Zobor, Katarína Štingl, Melanie Kempf, Fadi Nasser, Antje Bernd, Saskia Biskup, Frans P.M. Cremers, Muhammad Imran Khan, (unknown), Karin Schäferhoff, T. Heinrich, Tobias B. Haack, Bernd Wissinger, Eberhart Zrenner, Nicole Weisschuh, Susanne Kohl	18
20	Oscillatory Potentials in Achromatopsia as a Tool for Understanding Cone Retinal Functions 2021 ·International Journal of Molecular Sciences ·(unknown), Melanie Kempf, Christoph Braun, (unknown), Susanne Kohl, Bernd Wissinger, Eberhart Zrenner, Katarína Štingl, Krunoslav Stingl	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact